AACR 2026

Abstracts Sponsored by Bayer

April 17-22, 2026

Agenda of oral and poster presentations at the 2026 American Association for Clinical Research (AACR) Annual Meeting

Please see below to download a PDF for each presentation and view a video (where applicable). Access for each publication will be available after the congress presentation.

Please select a compound to navigate to all related publications.

LAROTRECTINIB

Larotrectinib (L) in patients (pts) with solid tumors with NTRK1/2/3 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Date/Time: Tuesday, April 21, 2026 | 9:00 AM – 12:00 PM

Session: Session PO.CTP01.03 - Phase II and Phase III Clinical Trials in Progress

Type: Poster

Presenting Author: Jordi Rodon

Poster Number: CT206/1

Download the poster

PIPELINE

Global first-in-human (FiH) monotherapy dose escalation trial of BAY2862789, a diacylglycerol kinase alpha (DGKα) selective intra-cellular T cell checkpoint inhibitor in solid tumors

Date/Time: Monday, April 20, 2026 | 2:00 PM – 5:00 PM

Session: Session PO.CT01.01 - Phase 0 and First-in-Human Phase I Clinical Trials

Type: Poster

Presenting Author: Shirish Madhav Gadgeel

Poster Number: CT131/23

Download the poster

First in human trial of BAY2965501, a selective inhibitor of intra-cellular T cell checkpoint diacylglycerol kinase zeta (DGKζ), as monotherapy and combination with anti-PD-1

Date/Time: Monday, April 20, 2026 | 2:00 PM – 5:00 PM

Session: Session PO.CT01.01 - Phase 0 and First-in-Human Phase I Clinical Trials

Type: Poster

Presenting Author: Jason Henry

Poster Number: CT132 / 24

Download the poster

Comparative evaluation of ²²⁵Ac-PSMA-Trillium with other ²²⁵Ac-PSMA-SMOL assets in a preclinical prostate cancer xenograft model

Date/Time: Wednesday, April 22, 2026 | 9:00 AM – 12:00 PM

Session: Session PO.ET08.03 - Targeted Radiopharmaceuticals and Combination Strategies in Cancer Therapy

Type: Poster

Presenting Author: Urs B. Hagemann

Poster Number: 7202/21

The compendium provided by Bayer is a compilation of Bayer sponsored presentations. Copies of presentations obtained from this compendium are for personal use only and may not be reproduced or distributed without permission from The American Association for Cancer Research (AACR) and from the authors. The compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities

For any questions, please contact Medical Information at 1-888-84-BAYER (1-888-842-2937), or visit go.bayer.com/vPIR